REBEKAH MOORE: Open Payments
NPI 1144576232 · BEDFORD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$380 in 20 payments from 14 companies in 2025. Trend: 2023 $93 · 2024 $0 · 2025 $380
Food & beverage: $380
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $67 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
| PFIZER INC. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Exact Sciences Corporation | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: CAPLYTA, VRAYLAR, COBENFY, REXULTI, MAVYRET, NURTEC ODT, JARDIANCE, Jornay PM.
Industry payments across IN — which companies pay providers there.
